Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib

Chronic myelomonocytic leukemia (CMML) is a heterogeneous neoplastic hematologic disorder with worse overall survival. Half of CMML have mutations, but case with concomitant mutations of DNA methyltransferase 3A (DNMT3A) and Internal tandem duplications of the juxtamembrane domain of FLT3 (FLT3-ITD)...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cancer Biol Ther
मुख्य लेखकों: Gu, Jia, Wang, Zhiqiong, Xiao, Min, Mao, Xia, Zhu, Li, Wang, Ying, Huang, Wei
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Taylor & Francis 2017
विषय:
Bedside to Bench Report
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710697/
https://ncbi.nlm.nih.gov/pubmed/28102729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2017.1281491
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन